Aguilella Vizcaíno, María José Cortés-Funes Castro, Hernán Cortijo Cascajares, Susana García Escobar, Ignacio Herreros de Tejada López-Coterilla, Alberto
Effectiveness of oxaliplatin desensitization protocols. [artículo] - Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013 - 15(3):219-25.
Formato Vancouver:
Cortijo-Cascajares S, Nacle-López I, García-Escobar I, Aguilella-Vizcaíno MJ, Herreros-de-Tejada A, Cortés-Funes Castro H et al. Effectiveness of oxaliplatin desensitization protocols. Clin Transl Oncol. 2013 Mar;15(3):219-25.
PMID: 22855191
Contiene 32 referencias
INTRODUCTION: Hypersensitivity reaction (HSR) to antineoplastic drugs can force doctors to stop treatment and seek other alternatives. These alternatives may be less effective, not as well tolerated and/or more expensive. Another option is to use desensitization protocols that induce a temporary state of tolerance by gradually administering small quantities of the antineoplastic drug until the therapeutic dosage is reached. The aim of this study is to assess the effectiveness of oxaliplatin desensitization protocols.
Effectiveness of oxaliplatin desensitization protocols. [artículo] - Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013 - 15(3):219-25.
Formato Vancouver:
Cortijo-Cascajares S, Nacle-López I, García-Escobar I, Aguilella-Vizcaíno MJ, Herreros-de-Tejada A, Cortés-Funes Castro H et al. Effectiveness of oxaliplatin desensitization protocols. Clin Transl Oncol. 2013 Mar;15(3):219-25.
PMID: 22855191
Contiene 32 referencias
INTRODUCTION: Hypersensitivity reaction (HSR) to antineoplastic drugs can force doctors to stop treatment and seek other alternatives. These alternatives may be less effective, not as well tolerated and/or more expensive. Another option is to use desensitization protocols that induce a temporary state of tolerance by gradually administering small quantities of the antineoplastic drug until the therapeutic dosage is reached. The aim of this study is to assess the effectiveness of oxaliplatin desensitization protocols.
